Day One Biopharmaceuticals, ImmunoGen And Other Big Stocks Moving Higher In Monday's Pre-Market Session

U.S. stock futures traded mixed this morning. Here are some big stocks recording gains in today’s pre-market trading session.

• Day One Biopharmaceuticals, Inc. (NASDAQ:DAWN) shares jumped 33.8% to $18.19 in pre-market trading after the company announced overall response rate of 67% and clinical benefit rate of 93% in 69 heavily pretreated RANO-HGG evaluable patients in pediatric low-grade glioma trial.
• ImmunoGen, Inc. (NASDAQ:IMGN) shares gained 14.3% to $16.43 in pre-market trading after the company announced that ELAHERE demonstrated 35% reduction in the risk of disease progression or death vs chemotherapy in FRα-Positive platinum-resistant ovarian cancer.
• Arlo Technologies, Inc. (NYSE:ARLO) shares rose 8.6% to $10.74 in pre-market trading. Arlo Technologies recently reported better-than-expected first-quarter financial results and issued revenue guidance above estimates.
• OraSure Technologies, Inc. (NASDAQ:OSUR) shares jumped 7% to $6.12 in pre-market trading. The company’s CFO Kenneth McGrath recently bought 100,000 shares at an average price of $4.93.
• Lilium N.V. (NASDAQ:LILM) shares climbed 5.6% to $1.12 in pre-market trading after dropping over 9% on Friday.
• Tremor International Ltd (NASDAQ:TRMR) shares gained 5.3% to $7.32 in pre-market trading. Tremor International recently reported better-than-expected first-quarter sales results.
• RLX Technology Inc. (NYSE:RLX) shares gained 5.1% to $1.88 in pre-market trading. RLX Technology recently reported a year-over-year decrease in first-quarter adjusted EPADS and sales results.
• Palo Alto Networks, Inc. (NASDAQ:PANW) shares rose 5% to $228.00 in pre-market trading. Palo Alto Networks recently reported upbeat quarterly results and raised its full-year guidance.

Now Read This: This Analyst With 85% Accuracy Rate Sees Over 52% Upside In Capri Holdings - Here Are 5 Stock Picks For Last Week From Wall Street's Most Accurate Analysts

Don’t forget to check out our premarket coverage here